cis-8,11,14-Eicosatrienoic Acid en es it fr

cis-8,11,14-Eicosatrienoic Acid Brand names, cis-8,11,14-Eicosatrienoic Acid Analogs

cis-8,11,14-Eicosatrienoic Acid Brand Names Mixture

  • No information avaliable

cis-8,11,14-Eicosatrienoic Acid Chemical_Formula

C20H34O2

cis-8,11,14-Eicosatrienoic Acid RX_link

No information avaliable

cis-8,11,14-Eicosatrienoic Acid fda sheet

cis-8,11,14-Eicosatrienoic Acid msds (material safety sheet)

http://www.caymanchem.com/msdss/90230m.pdf

cis-8,11,14-Eicosatrienoic Acid Synthesis Reference

No information avaliable

cis-8,11,14-Eicosatrienoic Acid Molecular Weight

306.487 g/mol

cis-8,11,14-Eicosatrienoic Acid Melting Point

No information avaliable

cis-8,11,14-Eicosatrienoic Acid H2O Solubility

No information avaliable

cis-8,11,14-Eicosatrienoic Acid State

Solid

cis-8,11,14-Eicosatrienoic Acid LogP

5.566

cis-8,11,14-Eicosatrienoic Acid Dosage Forms

No information avaliable

cis-8,11,14-Eicosatrienoic Acid Indication

For nutritional supplementation, also for treating dietary shortage or imbalance

cis-8,11,14-Eicosatrienoic Acid Pharmacology

Dihomo gamma-linolenic acid or DHLA is an n-6 (omega-6) polyunsaturated fatty acid. It is comprised of 20 carbon atoms and three double bonds. DHLA is a byproduct of the 18 carbon gamma-linolenic acid (GLA). DHLA is then converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect.

cis-8,11,14-Eicosatrienoic Acid Absorption

No information avaliable

cis-8,11,14-Eicosatrienoic Acid side effects and Toxicity

No information avaliable

cis-8,11,14-Eicosatrienoic Acid Patient Information

No information avaliable

cis-8,11,14-Eicosatrienoic Acid Organisms Affected

Humans and other mammals